Search Videos and More
Document
Treatment Guideline: Adjuvant Ribociclib for Early-Stage Hormone Receptor-Positive Breast Cancer - Updated in 2025
The Breast Oncology Center at Dana-Farber Brigham Cancer Center held multidisciplinary meetings to discuss recommendations regarding the use of adjuvant ribociclib in patients with early-stage hormone receptor-positive breast cancer.
Document
Treatment Guideline: Patients With a History of Breast Cancer who Desire Pregnancy
The Breast Oncology Center at Dana-Farber Brigham Cancer Center held multidisciplinary meetings to discuss recommendations for patients with a history of breast cancer who desire pregnancy.
News
New Guidelines for Radiation Therapy for HPV-associated Head and Neck Cancer
Radiation therapy for HPV-positive oropharyngeal squamous cell carcinoma: An ASTRO clinical practice guideline
News
Anti-inflammatory Drug Celecoxib Could Reduce Risk of Colon Cancer Recurrence for a Subset of Patients
Review analysis of data from a randomized clinical trial for patients with stage 3 colon cancer
Video
Kimia Sorouri, MD, MPH Discusses Fertility and Breast Cancer
Study shows most women attempting to conceive after breast cancer treatment can do so and give birth. Dana-Farber's Kimia Sorouri, MD, MPH, discusses the first prospective study with more than 10 years of follow-up that also accounts for conception attempts.
Video
Toni Choueiri, MD Provides Kidney Cancer CLEAR Trial biomarker analysis
Biomarker analysis in the phase 3 CLEAR trial shows biomarkers don't impact the superiority of lenvatinib plus pembrolizumab versus sunitinib as a first-line therapy in patients diagnosed with advanced kidney cancer.
Video
Toni Choueiri, MD Discusses Kidney Cancer JAVELIN 101
Kidney cancer research at ASCO24: Final analysis in JAVELIN Renal 101 trial confirms the efficacy and manageable safety profile of avelumab plus axitinib versus sunitinib in patients with advanced kidney cancer. Dana-Farber's Toni Choueiri, MD, explains more.
Video
Andrew Hantel, MD Reviews Cancer Care and Greenhouse Gases
Telehealth can significantly reduce greenhouse gas emissions from cancer care, with research showing decentralized cancer care and telemedicine can cut emissions 33% compared to traditional in-person visits.
Video
Richard Leiter, MD, MA Featured in ASCO Voices
Palliative care physician Richard Leiter, MD, MA, recounts his support of a young patient with end-of-life care and the complexities of communicating with his family.
Video
Jia Luo, MD Discusses NUT Carcinoma
NUT Carcinoma may not be as rare as one thought. Jia Luo, MD, of Dana-Farber, shares new efforts to research this type of rare cancer that can grow anywhere in the body, often in the head, neck and lungs.
Video
Lakshmi Nayak, MD Discusses CNS Lymphoma
CNS Lymphoma research at ASCO24: Dana-Farber's Lakshmi Nayak, MD, details findings of a pilot study showing a CAR T-cell therapy has shown promise and is safe and well-tolerated in treating patients with relapsed, treatment-resistant CNS lymphoma.
Video
Narjust Florez, MD Discusses Young Lung Cancer
Lung cancer rates in younger adults are rising. Dana-Farber's Narjust Florez, MD discusses research showing that young patients with lung cancer face ample financial toxicity and issues impacting physical, emotional, and functional well-being.